While COVID-19 caused many to shy away from in-person visits with a healthcare provider, a Healthgrades study published in May notes that consumer confidence is on the upswing. The COVID-19 Patient Confidence Study, a weekly...
Game theory could be the key to identifying dangerous antimicrobial-resistant bacteria.
Current antibiotic treatments for Clostridioides difficile infection (CDI), which causes the chronic, degenerative disease colitis, eliminate beneficial bacteria in the gut along with the harmful pathogen. Researchers at North Carolina State University (NCSU) have taken the first step toward developing a therapy that attacks C. difficile while sparing other microbes.
Two recently approved treatments show promise in a new study.
The recent FDA approval of the drug Tukysa (tucatinib) for use with the chemotherapeutic agents trastuzumab and capecitabine provides a new treatment option to certain adults with HER2-positive breast cancer.
To further illustrate the mental and physical health benefits of exercise, the American Academy of Pediatrics recommends pediatricians encourage physical activity in patients.
A pediatric cancer patient and his or her family’s main concern should focus on oncology treatments, not if those treatments will cause future infertility. As oncology advances, so do fertility preservation options.